Animal models in regenerative medicine in upcoming special issue of tissue engineering

October 24, 2017

New Rochelle, NY, Oct. 24, 2017 -- Novel approaches to tissue engineering and regenerative medicine are first evaluated and optimized in animal models before making the leap to clinical testing in human subjects. For many of these innovative new techniques and materials to succeed and advance to the clinic, the selection of an appropriate animal model and design of the experiments to gauge performance and outcomes can determine whether a particular approach, and the field in general, continue to move forward. A special issue devoted to the latest research on using animal models in regenerative medicine research is forthcoming in Tissue Engineering, Part C, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Select articles from the issue are now available online on the Tissue Engineering website.

Guest Editors Jorge Piedrahita, PhD, North Carolina State University College of Veterinary Medicine, Raleigh, and J. Koudy Williams, DVM, Wake Forest School of Medicine, Winston Salem, NC oversaw the development of the special issue. They compiled a series of outstanding papers on diverse topics contributed by leading researchers. These include the article entitled "Inflammation-Induced Osteogenesis in a Rabbit Tibia Model," in which F. Cumhur Öner, MD, PhD, et al., University Medical Center Utrecht, Delft University of Technology, and Utrecht University, The Netherlands, examined the inflammatory responses to bacterial infection that can promote bone formation. The researchers showed that the inflammatory response caused by exposure to Staphylococcus aureus antigens, in the absence of bacterial infection, could stimulate bone growth and might be a useful strategy in bone regenerative medicine.

In the article "Rise of the Pigs: Utilization of the Porcine Model to Study Musculoskeletal Biomechanics and Tissue Engineering During Skeletal Growth," Matthew Fisher, PhD and coauthors from North Carolina State University, University of North Carolina at Chapel Hill and UNC School of Medicine, present the unique opportunities and challenges for using pigs as translational models in the development of musculoskeletal regenerative medicine approaches. In particular, the researchers describe the advantages porcine models offer for studying biomechanics.

Johan Lammens, MD, PhD and coauthors from University Hospitals KU Leuven, KU Leuven, Medanex Clinic (Diest), and University of Liège, Belgium, caution that techniques for repairing large bone defects developed in the laboratory will only ultimately be successful in humans if the preclinical studies are performed in a reliable animal model using a bone defect of sufficient size created by following well-defined methods. They share their perspectives in the article entitled "Warning About the Use of Critical-Size Defects for the Translational Study of Bone Repair: Analysis of a Sheep Tibial Model."

"This special issue emphasizes not only the need for appropriate animal models to increase our understanding and knowledge, but also for the final clinical application of regenerative medicine-based products," says Methods Co-Editor-in-Chief John A. Jansen, DDS, PhD, Professor and Head, Department of Biomaterials, Radboud University Medical Center, The Netherlands.
Click here to register to be notified when the complete special issue on Animal Models is published.

Research reported in this publication was supported by the National Institutes of Health under Award Number R03AR068112. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About the Journal

Tissue Engineering is an authoritative peer-reviewed journal published 42 times per year online and in print in three parts: Part A, the flagship journal, published 24 times per year; Part B: Reviews, published bimonthly, and Part C: Methods, published 12 times per year. Led by Co-Editors-In-Chief Antonios G. Mikos, PhD, Louis Calder Professor at Rice University, Houston, TX, and Peter C. Johnson, MD, Principal, MedSurgPI, LLC and President and CEO, Scintellix, LLC, Raleigh, NC, the Journal brings together scientific and medical experts in the fields of biomedical engineering, material science, molecular and cellular biology, and genetic engineering. Leadership of Tissue Engineering Parts B (Reviews) and Part C (Methods) is provided by John P. Fisher, PhD, University of Maryland and John A. Jansen, DDS, PhD, Radboud University, respectively. Complete tables of content and a sample issue may be viewed online at the Tissue Engineering website. Tissue Engineering is the official journal of the Tissue Engineering & Regenerative Medicine International Society (TERMIS). Complete tables of content and a sample issue may be viewed on the Tissue Engineering website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Stem Cells and Development, Human Gene Therapy, and Advances in Wound Care. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc./Genetic Engineering News

Related Regenerative Medicine Articles from Brightsurf:

Stem cells: new insights for future regenerative medicine approaches
The study published in Open Biology unravels important data for a better understanding of the process of division in stem cells and for the development of safer ways to use them in medicine.

Engineered developmental signals could illuminate regenerative medicine
For a tiny embryo to develop into an adult organism, its cells must develop in precise patterns and interact with their neighbors in carefully orchestrated ways.

A new discovery in regenerative medicine
An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.

New research into stem cell mutations could improve regenerative medicine
Research from the University of Sheffield has given new insight into the cause of mutations in pluripotent stem cells and potential ways of stopping these mutations from occurring.

Keratin scaffolds could advance regenerative medicine and tissue engineering for humans
Researchers at Mossakowski Medical Research Center of the Polish Academy of Science have developed a simple method for preparing 3D keratin scaffold models which can be used to study the regeneration of tissue.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

A new material for regenerative medicine capable to control cell immune response
Scientists of Tomsk Polytechnic University jointly with the University of Montana (USA) proposed a new promising material for regenerative medicine for recovery of damaged tissues and blood vessels.

Optoceutics: A new technique using light for regenerative medicine
Researchers in Italy at IIT-Istituto Italiano di Tecnologia used visible light together with photo-sensitive and biocompatible materials to facilitate the formation of new blood vessels in vitro.

Major stem cell discovery to boost research into development and regenerative medicine
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells.

Spinning-prism microscope helps gather stem cells for regenerative medicine
Pluripotent stem cells are crucial to regenerative medicine, but better screening methods are needed to isolate safe and effective cells for medical use.

Read More: Regenerative Medicine News and Regenerative Medicine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to